Clinical experience with pemigatinib for previously treated metastatic cholangiocarcinoma: practical considerations from clinical cases

The management of advanced cholangiocarcinoma (CCA) is challenging. In patients with advanced CCA, gemcitabine/cisplatin combination is the standard frontline chemotherapy, with 5-fluorouracil-based regimens preserved for subsequent lines; however, the expected survival is poor. Pemigatinib was appr...

Descripción completa

Detalles Bibliográficos
Autores principales: Wadsley, Jonathan, Christie, Alan, Gillmore, Roopinder, Trinh, Amy, Greig, Rachel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioExcel Publishing Ltd 2023
Materias:
Case Series
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10435267/
https://www.ncbi.nlm.nih.gov/pubmed/37602357
http://dx.doi.org/10.7573/dic.2023-5-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10435267/
https://www.ncbi.nlm.nih.gov/pubmed/37602357
http://dx.doi.org/10.7573/dic.2023-5-5

Ejemplares similares